7Baggers

We provide you with 20 years of free, institutional-grade data for RPRX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of RPRX. Explore the full financial landscape of RPRX stock.

Reported DateCIKTickerType
2025-08-061802768RPRX10-QUrl
2025-05-081802768RPRX10-QUrl
2025-02-121802768RPRX10-KUrl
2024-11-061802768RPRX10-QUrl
2024-08-081802768RPRX10-QUrl
2024-05-091802768RPRX10-QUrl
2024-02-151802768RPRX10-KUrl
2023-11-081802768RPRX10-QUrl
2023-08-081802768RPRX10-QUrl
2023-05-091802768RPRX10-QUrl
2023-02-151802768RPRX10-KUrl
2022-11-081802768RPRX10-QUrl
2022-08-041802768RPRX10-QUrl
2022-05-051802768RPRX10-QUrl
2022-02-151802768RPRX10-KUrl
2021-11-101802768RPRX10-QUrl
2021-08-111802768RPRX10-QUrl
2021-05-111802768RPRX10-QUrl
2021-02-241802768RPRX10-KUrl
2020-11-121802768RPRX10-QUrl
2020-10-131802768RPRXS-1Url
2020-08-121802768RPRX10-QUrl
2020-05-221802768RPRXS-1Url

Royalty Pharma plc
(NASDAQ:RPRX) 

RPRX stock logo

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the compa...

Founded: 1996
CEO: Pablo Gerardo Legorreta  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends
The information provided in this report about RPRX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.